Johnson & Johnson's stock declines 0.71% amid mixed institutional investment activities.
In the past 24 hours, Johnson & Johnson's (JNJ) stock experienced a slight decline of 0.71%, closing at $267.08. This movement coincided with recent institutional investment activities, including a 1.9% increase in holdings by Braun Stacey Associates Inc., which now owns 156,008 shares valued at approximately $39.6 million. Conversely, Addison Advisors LLC reduced its stake by 78.4%, selling 7,675 shares and retaining 2,109 shares valued at about $536,000. These mixed investment actions may reflect varied institutional perspectives on JNJ's current valuation and prospects.
Key points
- Braun Stacey Associates Inc. increased its JNJ holdings by 1.9%, now owning 156,008 shares valued at approximately $39.6 million.
- Addison Advisors LLC reduced its JNJ stake by 78.4%, selling 7,675 shares and retaining 2,109 shares valued at about $536,000.
- Johnson & Johnson's stock closed at $267.08, down 0.71% from the previous close.
Sources
AI-generated from public news sources. Not financial advice.

